PTCH mutations also give rise to the naevoid basal cell carcinoma syndrome (NBCCS), known as Gorlin syndrome, which is characterized by predispositions to develop basal cell carcinomas (BCC), medulloblastoma (MB) and RMS [4–6]. This evidence concerns the gene PTCH1 and skin basal cell carcinoma.